MarketBeat Daily Ratings for Tuesday, June 17, 2025
Ratings changes for SolarEdge Technologies, Enphase Energy, Sunrun, NVIDIA, Cooper Companies, monday.com, TransMedics Group and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.June 17th, 2025 Today's Top Stories | | By Nathan Reiff | June 17, 2025 06:58 AM |
| | | By Chris Markoch | June 17, 2025 06:02 AM |
| | By The Associated Press | June 17, 2025 04:00 AM |
| | | By The Associated Press | June 16, 2025 11:33 PM |
| | By The Associated Press | June 16, 2025 04:38 PM |
|
|
Analysts' Upgrades | | Alkermes (NASDAQ:ALKS) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $42.00 price target on the stock, up previously from $33.00. This represents a 38.1% upside from the current price of $30.41. | | Cooper Companies (NASDAQ:COO) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $94.00 price target on the stock. This represents a 34.6% upside from the current price of $69.85. | | Comstock Resources (NYSE:CRK) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock. This represents a 25.1% upside from the current price of $27.19. | | NIO (NYSE:NIO) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $3.80 price target on the stock, up previously from $3.70. This represents a 8.9% upside from the current price of $3.49. | | Roku (NASDAQ:ROKU) was upgraded by analysts at Loop Capital from a "hold" rating to a "buy" rating. They now have a $100.00 price target on the stock, up previously from $80.00. This represents a 21.9% upside from the current price of $82.06. | | XPeng (NYSE:XPEV) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $24.00 price target on the stock, up previously from $16.40. This represents a 27.9% upside from the current price of $18.77. |
|
View More Upgrades
|
Analysts' Downgrades | | Cantaloupe (NASDAQ:CTLP) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $11.20 price target on the stock, down previously from $11.50. This represents a 2.3% upside from the current price of $10.95. | | Enphase Energy (NASDAQ:ENPH) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $31.00 price target on the stock. This represents a 8.9% downside from the current price of $34.02. | | FrontView REIT (NYSE:FVR) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $12.00 price target on the stock, down previously from $14.00. This represents a 9.4% upside from the current price of $10.96. | | Health Catalyst (NASDAQ:HCAT) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $3.76. | | Nutrien (NYSE:NTR) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating. They now have a $68.00 price target on the stock. This represents a 8.9% upside from the current price of $62.45. | | Navitas Semiconductor (NASDAQ:NVTS) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $3.50 price target on the stock. This represents a 47.5% downside from the current price of $6.67. | | Sunrun (NASDAQ:RUN) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $6.00 price target on the stock. This represents a 8.2% upside from the current price of $5.55. | | SolarEdge Technologies (NASDAQ:SEDG) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $16.00 price target on the stock. This represents a 9.0% upside from the current price of $14.68. | | Millicom International Cellular (NASDAQ:TIGO) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $37.00 price target on the stock. This represents a 1.1% downside from the current price of $37.42. |
|
View More Downgrades
|
Analysts' New Coverage | | Acumen Pharmaceuticals (NASDAQ:ABOS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $4.00 price target on the stock. This represents a 236.1% upside from the current price of $1.19. | | Arcellx (NASDAQ:ACLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $110.00 price target on the stock. This represents a 71.8% upside from the current price of $64.05. | | Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 119.4% upside from the current price of $5.47. | | Artivion (NYSE:AORT) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 20.9% upside from the current price of $28.96. | | ASML (NASDAQ:ASML) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $806.00 price target on the stock. This represents a 5.6% upside from the current price of $763.52. | | BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $49.00 price target on the stock. This represents a 20.5% upside from the current price of $40.67. | | Coinbase Global (NASDAQ:COIN) is now covered by analysts at China Renaissance. They set a "buy" rating and a $353.30 price target on the stock. This represents a 37.7% upside from the current price of $256.49. | | EOG Resources (NYSE:EOG) is now covered by analysts at Stephens. They set an "equal weight" rating and a $137.00 price target on the stock. This represents a 9.3% upside from the current price of $125.34. | | EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 202.1% upside from the current price of $9.27. | | Flotek Industries (NYSE:FTK) is now covered by analysts at Northland Securities. They set a "market perform" rating and a $16.00 price target on the stock. This represents a 3.6% upside from the current price of $15.44. | | Galectin Therapeutics (NASDAQ:GALT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $6.00 price target on the stock. This represents a 239.6% upside from the current price of $1.77. | | Mayville Engineering (NYSE:MEC) is now covered by analysts at DA Davidson. They set a "buy" rating and a $23.00 price target on the stock. This represents a 50.6% upside from the current price of $15.27. | | monday.com (NASDAQ:MNDY) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $330.00 price target on the stock. This represents a 16.8% upside from the current price of $282.47. | | NewAmsterdam Pharma (NASDAQ:NAMS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 114.7% upside from the current price of $19.56. | | Nordson (NASDAQ:NDSN) is now covered by analysts at Vertical Research. They set a "hold" rating and a $245.00 price target on the stock. This represents a 12.0% upside from the current price of $218.68. | | Neurogene (NASDAQ:NGNE) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $50.00 price target on the stock. This represents a 159.7% upside from the current price of $19.26. | | Novavax (NASDAQ:NVAX) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $6.00 price target on the stock. This represents a 11.2% downside from the current price of $6.76. | | PTC Therapeutics (NASDAQ:PTCT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $80.00 price target on the stock. This represents a 54.5% upside from the current price of $51.76. | | Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock. This represents a 31.8% upside from the current price of $54.63. | | Avidity Biosciences (NASDAQ:RNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $55.00 price target on the stock. This represents a 78.9% upside from the current price of $30.74. | | SAP (NYSE:SAP) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.The current price is $295.37. | | Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $22.08. | | Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Jones Trading. They set a "buy" rating and a $24.00 price target on the stock. This represents a 124.5% upside from the current price of $10.69. | | Venture Global (NYSE:VG) is now covered by analysts at Johnson Rice. They set a "buy" rating and a $20.00 price target on the stock. This represents a 15.7% upside from the current price of $17.29. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Volatility Is Rising—But These 2 AI Stocks Could Thrive (Click to Opt-In) |
